Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition

A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024.A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.There may be a new, unintended side effect linked to Novo Nordisk's blockbuster diabetes injection, Ozempic. Danish health authorities on Monday said they are asking the European Union's drug regulator to review the findings of two D ...